SPOTLIGHT -
EP. 1: Locally Advanced NSCLC: Approaching the PACIFIC Trial
EP. 2: Global Perspectives on the PACIFIC Trial in NSCLC
EP. 3: Appropriate Settings for the PACIFIC Regimen in NSCLC
EP. 4: Advanced-Stage NSCLC: KEYNOTE-189's Role in Treatment
EP. 5: Personal Use of I-O Therapy in Advanced-Stage NSCLC
EP. 6: Treatment After Progression in Advanced-Stage NSCLC
EP. 7: CheckMate 227: TMB Versus PD-L1 in Advanced-Stage NSCLC
EP. 8: Managing Oligometastases With Ablative Therapy in NSCLC
EP. 9: Osimertinib's Role in EGFR+ Metastatic Lung Cancer
EP. 10: Global Perspectives on Use of Osimertinib in EGFR+ NSCLC
EP. 11: Changing the Treatment Paradigm for ALK-Rearranged NSCLC
EP. 12: Sequencing Therapies in ALK-Rearranged NSCLC
EP. 13: Considering Targeted Agents in BRAF-Mutant NSCLC
EP. 14: Other Targeted Approaches in NSCLC: NTRK or RET Fusions
EP. 15: Take-Home Messages on the NSCLC Treatment Paradigm
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
